%0 Journal Article
%T Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?
%A Behl¨¹l Kahyao£¿lu
%A Fatma Behice Cinemre
%A Mehmet B¨¹lent Vatan
%A Muhammed Murat Necati Aksoy
%A Mustafa Tar£¿k A£¿a£¿
%A Yasemin G¨¹nd¨¹z
%J Archive of "Anatolian Journal of Cardiology".
%D 2019
%R 10.14744/AnatolJCardiol.2018.25564
%X Identification of the asymptomatic target organ damage (AOD) helps to stratify the overall risk of cardiovascular (CV) diseases and guides a treatment decision in hypertensive patients without a symptomatic CV or renal disease. The endothelial-cell-specific molecule 1 (endocan) is regarded as a novel marker of endothelial dysfunction. Its release is increased in hypertensive patients, especially those with symptomatic CV and renal disease. In the present study, we aimed to evaluate the endocan levels in asymptomatic hypertensive patients with or without AOD
%K endocan
%K asymptomatic target organ damage
%K hypertension
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457429/